190 related articles for article (PubMed ID: 31536956)
41. Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.
Coşkun GP; Djikic T; Hayal TB; Türkel N; Yelekçi K; Şahin F; Küçükgüzel ŞG
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082676
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
43. Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.
Bagul C; Rao GK; Veena I; Kulkarni R; Tamboli JR; Akunuri R; Shaik SP; Pal-Bhadra M; Kamal A
Mol Divers; 2023 Jun; 27(3):1185-1202. PubMed ID: 36114912
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors.
Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A
Bioorg Med Chem Lett; 2003 Feb; 13(4):657-60. PubMed ID: 12639552
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
[TBL] [Abstract][Full Text] [Related]
46. Thieno[2,3-d]pyrimidines in the synthesis of antitumor and antioxidant agents.
Aly AA; Brown AB; Ramadan M; Gamal-Eldeen AM; Abdel-Aziz M; Abuo-Rahma Gel-D; Radwan MF
Arch Pharm (Weinheim); 2010 May; 343(5):301-9. PubMed ID: 20232374
[TBL] [Abstract][Full Text] [Related]
47. A promising anti-cancer and anti-oxidant agents based on the pyrrole and fused pyrrole: synthesis, docking studies and biological evaluation.
Fatahala SS; Shalaby EA; Kassab SE; Mohamed MS
Anticancer Agents Med Chem; 2015; 15(4):517-26. PubMed ID: 25929576
[TBL] [Abstract][Full Text] [Related]
48. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
49. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation.
Xiang P; Zhou T; Wang L; Sun CY; Hu J; Zhao YL; Yang L
Molecules; 2012 Jan; 17(1):873-83. PubMed ID: 22252503
[TBL] [Abstract][Full Text] [Related]
50. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
[TBL] [Abstract][Full Text] [Related]
51. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors.
El-Helby AA; Sakr H; Eissa IH; Abulkhair H; Al-Karmalawy AA; El-Adl K
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900113. PubMed ID: 31448458
[TBL] [Abstract][Full Text] [Related]
53. Synthetic methodology-enabled discovery of a tunable indole template for COX-1 inhibition and anti-cancer activity.
Guerra Faura G; Wu B; Oyelere AK; France S
Bioorg Med Chem; 2022 Mar; 57():116633. PubMed ID: 35134642
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
Shaaban S; Ashmawy AM; Negm A; Wessjohann LA
Eur J Med Chem; 2019 Oct; 179():515-526. PubMed ID: 31276896
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.
Kumar D; Jacob MR; Reynolds MB; Kerwin SM
Bioorg Med Chem; 2002 Dec; 10(12):3997-4004. PubMed ID: 12413851
[TBL] [Abstract][Full Text] [Related]
57. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives.
Mishra VR; Ghanavatkar CW; Mali SN; Qureshi SI; Chaudhari HK; Sekar N
Comput Biol Chem; 2019 Feb; 78():330-337. PubMed ID: 30639681
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
60. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
Alegaon SG; Alagawadi KR; Garg MK; Dushyant K; Vinod D
Bioorg Chem; 2014 Jun; 54():51-9. PubMed ID: 24793214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
